biogen
-
Isis, Biogen Strike Potential $299M Deal For Rare Spine Disorder Treatment
Isis Pharmaceuticals has found a new partner in Biogen Idec that’s betting a large amount of money on a new therapy for a rare…
Read More »
Isis Pharmaceuticals has found a new partner in Biogen Idec that’s betting a large amount of money on a new therapy for a rare…
Read More »